Esophageal adenocarcinoma typically has a poor prognosis at the time of diagnosis. Consequently, palliation of symptoms is vital to disease management with a cornerstone for palliation being esophageal stent placement. Esophageal stents are associated with a variety of complications that may present immediately or long after stent placement is completed. In this report, we present a 58-year-old male who developed shortness of breath 4 months after metallic esophageal stent placement. After further evaluation with a chest radiograph and CT angiogram of the chest, the patient was found to have obstruction of the left mainstem bronchus secondary to mass effect from the esophageal stent. Airway compromise secondary to metallic esophageal stent placement typically occurs immediately after placement of the stent. There are only a few documented cases of this complication occurring at a delayed interval. This case clearly demonstrates this rare complication of esophageal stent placement in the setting of esophageal adenocarcinoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319639PMC
http://dx.doi.org/10.1016/j.radcr.2023.06.007DOI Listing

Publication Analysis

Top Keywords

esophageal stent
24
stent placement
24
esophageal
9
stent
8
esophageal adenocarcinoma
8
metallic esophageal
8
placement
7
delayed bronchial
4
bronchial obstruction
4
obstruction esophageal
4

Similar Publications

Endoluminal Wound Vacuum Therapy: A Paradigm Shift in Managing Esophageal Bronchial Fistula.

Ann Thorac Surg Short Rep

December 2024

Division of Thoracic Surgery, Department of Surgery, Houston Methodist Hospital, Houston, Texas.

Esophageal bronchial fistula after Ivor Lewis esophagectomy is a challenging complication. Surgical treatment is definitive, but it carries high morbidity and mortality, whereas esophageal stents have been shown to be temporary measures. We highlight the case of a patient who was treated with endoluminal wound vacuum therapy.

View Article and Find Full Text PDF

Purpose: This study assesses the efficacy and safety of Portal Vein Recanalization with Intrahepatic Portosystemic Shunt (PVR-TIPS) in non-cirrhotic patients with chronic portal vein occlusion (CPVO), cavernomatous transformation, and symptomatic portal hypertension (PH) and/or portal vein thrombotic progression.

Material And Methods: Medical records of 21 non-cirrhotic patients with CPVO and portal cavernoma undergoing PVR-TIPS were analyzed. Hemodynamic (intraprocedural reduction in portosystemic pressure gradient), clinical (data on gastrointestinal bleeding, abdominal pain, ascites, and presence of esophageal varices from imaging exams) and technical success (PVR-TIPS) assessed efficacy.

View Article and Find Full Text PDF

Objective: The study objective was to assess the efficacity of different surgical strategies for atrioesophageal fistula after catheter ablation of atrial fibrillation.

Methods: Between January 2010 and April 2023, all patients with a diagnosis of atrioesophageal fistula or pericardo-esophageal fistula after catheter ablation of atrial fibrillation were analyzed retrospectively from the French database EPITHOR. Patients without surgical management were excluded.

View Article and Find Full Text PDF

An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment.

Mater Today Bio

February 2025

Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.

Article Synopsis
  • Esophageal cancer ranks as the eighth most common type of cancer globally and is the sixth leading cause of cancer-related deaths.
  • The study introduces an innovative esophageal stent that features a wireless, battery-free, movable photodynamic therapy (PDT) unit, designed for flexible and precise treatment of esophageal tumors.
  • The system integrates a light source for PDT to induce tumor cell death and an electrochemical pneumatic actuator that allows for real-time positioning of the light source, improving targeted therapy based on tumor progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!